Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd.
- Market cap
- $1.09B
Your view on DRTSW
Overview
What the company does, where it operates, and who runs it.
About Alpha Tau Medical Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Uzi Sofer
- Headquarters
- Kiryat HaMada St. 5, Jerusalem, JM, IL
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Uzi Sofer
- Headquarters
- Kiryat HaMada St. 5, Jerusalem, JM, IL
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer.
The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Alpha Tau Medical Ltd.. Starting points for Alpha Tau Medical Ltd.: EPS -$1.20, beta 1.19 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Alpha Tau Medical Ltd.. Trailing twelve-month EPS for Alpha Tau Medical Ltd. stands at -$1.20. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.15 | −$0.15 | −$1.07 | −$0.54 |
| Lowest estimate | −$0.15 | −$0.15 | −$1.07 | −$0.54 |
| Highest estimate | −$0.15 | −$0.15 | −$1.07 | −$0.54 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | −$0.14 | −$0.261 | −$0.53 | — |
| Growth vs a year ago | −7.1% | — | −101.5% | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $250000.00 | $533333.00 | $375000.00 | $10.72M |
| Lowest estimate | $250000.00 | $533333.00 | $375000.00 | $10.72M |
| Highest estimate | $250000.00 | $533333.00 | $375000.00 | $10.72M |
| Number of analysts | 3 | 2 | 3 | 3 |
| A year ago | $0.00 | $0.00 | $0.00 | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Alpha Tau Medical Ltd.. Alpha Tau Medical Ltd. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| CATXPerspective Therapeutics, Inc. | Healthcare | Medical - Devices | $91.0M | ||
| RADXRadiopharm Theranostics Limited | Healthcare | Biotechnology | $812,081 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | Healthcare | NASDAQ | $16.6B | ||
| ASPEAspen Neuroscience Inc. | Healthcare | NASDAQ | $361.2M | ||
| ASPHFAscentage Pharma Group International | Healthcare | OTC | $3.2B | ||
| ATAIAtai Life Sciences N.V. | Healthcare | NASDAQ | $2.7B | ||
| ATGGFActinogen Medical Limited | Healthcare | OTC | $107.7M | ||
| ATH.AXAlterity Therapeutics Limited | Healthcare | ASX | — | ||
| ATHEAlterity Therapeutics Limited | Healthcare | NASDAQ | $25.8M | ||
| ATNMActinium Pharmaceuticals, Inc. | Healthcare | AMEX | $33.0M | ||
| ATOSAtossa Therapeutics, Inc. | Healthcare | NASDAQ | $15.9M | ||
| ATRAAtara Biotherapeutics, Inc. | Healthcare | NASDAQ | $64.5M | ||
| ATRXAdhera Therapeutics, Inc. | Healthcare | OTC | $722 | ||
| ATX.AXAmplia Therapeutics Limited | Healthcare | ASX | — | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Alpha Tau Medical Ltd., and how their positions are changing. At a $1.09B market value, institutional positions materially move Alpha Tau Medical Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Alpha Tau Medical Ltd. executives and directors. Shares of Alpha Tau Medical Ltd. have traded between $0.33 and $3.40 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Alpha Tau Medical Ltd.